Laboratory investigation of sputum and mucociliary clearance (MCC) condition in patients with COPD Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002
Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD Source: Eur Respir J 2013; 41: 1042-1050 Year: 2013
Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018
Effects of β2 agonists on mucociliary clearance (MCC) in patients with asthma - association to polymorphisms of the β2-adrenoceptor Source: Eur Respir J 2003; 22: Suppl. 45, 478s Year: 2003
Interrelationship between clinical symptoms expressiveness and brush-biopsy cell count and proteinases and its inhibitors in sputum at smokers and nonsmokers with COPD Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011
Relationship between COPD assessment test (CAT) and declines of lung function in COPD patients Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012
Bronchophonographia (BPG) in evaluation of lung function in children with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 496s Year: 2003
Relationship between nasal potential difference (NPD) and respiratory function in cystic fibrosis (CF) patients Source: Eur Respir J 2001; 18: Suppl. 33, 125s Year: 2001
Evaluation of high sensitivity C reactive protein in patients of bronchial asthma and its correlation with exacerbation rate and pulmonary function Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
Assessment of airway pathology in COPD patients by a visual endoscopic scoring system and its relation to BAL, sputum and lung function Source: Eur Respir J 2002; 20: Suppl. 38, 403s Year: 2002
Relationship of lung function to asthma severity in asthmatic families Source: Eur Respir J 2005; 26: Suppl. 49, 397s Year: 2005
Plasma surfactant protein-D (SPD) concentration and severity of airflow limitation in COPD patients (pts) Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP) Source: International Congress 2014 – Clinical presentations Year: 2014
Induced sputum in asthma and COPD: meassuring type and inflammation activity Source: Eur Respir J 2003; 22: Suppl. 45, 76s Year: 2003
Functional activity of bronchial neutrophils in the patients with cold airway hyperresponsiveness (CAHR) in severe asthma Source: International Congress 2017 – Translational studies of lung disease Year: 2017
Functional correlations between bronchial brush-biopsy composition and proteinases and its inhibitors in sputum in smokers and nonsmokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 578s Year: 2006
Proteolytic activity of sputum and serum in patients with COPD exacerbation in dependence on smoking Source: Eur Respir J 2003; 22: Suppl. 45, 416s Year: 2003
Mucociliary clearance (MCC) in the trachea in mild-moderate COPD occurs in spirals Source: International Congress 2015 – Pathophysiological mechanisms at different scales: lung, airways, muscles and symptom perception Year: 2015
Microbiological features of the indicators of bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) during remission Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019